Journal
BIOTECHNOLOGY PROGRESS
Volume 28, Issue 1, Pages 257-264Publisher
WILEY
DOI: 10.1002/btpr.728
Keywords
polycation; biocompatibility; self-assembly
Funding
- NSF [DMR 1005766]
- Division Of Materials Research
- Direct For Mathematical & Physical Scien [1005766] Funding Source: National Science Foundation
Ask authors/readers for more resources
Polycations are very useful in biotechnology. However, most existing polycations have high toxicity that significantly limits their clinical translation. We designed poly(ethylene argininylaspartate diglyceride) (PEAD) that is based on arginine, aspartic acid, glycerol, and ethylene glycol. A set of in vitro assays demonstrated that PEAD exhibited no cytotoxicity at 1 mg/mL, which is at least 100 times higher than the widely used polycation-polyethylenimine. Subcutaneous injection of 1 mg PEAD in rats did not cause an adverse response acutely or after 4 weeks. Zeta potential measurements revealed that PEAD has high affinity to biological polyanions such as DNA and hyaluronic acid. This polycation represents a new platform of biocompatible polycations that may lead to clinical innovations in gene therapy, controlled release, tissue engineering, biosensors, and medical devices (c) 2011 American Institute of Chemical Engineers Biotechnol. Prog., 2012
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available